The India Investor AI Stack in 2026: Screener, Multibagg Iris, and FinGenie

Indian investors keep asking the same wrong question: which single AI should I pay for? Multibagg or Screener AI? ChatGPT or Perplexity? FinGenie or Iris? The market rewards that confusion with listicles and pricing pages. The investor who actually compounds skill asks a better question: which job am I doing right now, and which tool owns that job?

By mid-2026 the India retail toolkit has split into clear layers. Screener.in still owns fundamentals and screening. Multibagg Iris owns conversational company and portfolio research with a serious paid tier. Screener AI owns metered filing Q&A on company pages. Moneycontrol still owns speed of news. FynSight FinGenie owns market character: regime, FII/DII streaks, sector ranks, breadth, and crypto cycle context.

This article is the stack guide. Not a fake ranking where FinGenie magically beats everyone at filings. An honest map of who wins which job, what each costs, and how to sequence them after the closing bell. Observations only. Not investment advice. FynSight is not a SEBI-registered investment advisor.

Job one is market character. What kind of day and week is this? Broad Expansion or Narrow Leadership? Are FIIs selling on a streak while DIIs absorb? Is breadth confirming the index? That job decides how much weight you give any single stock story.

Job two is idea generation. Screens, themes, peer lists, IPO calendars. Screener custom ratios and Multibagg discovery buckets live here. Job three is company diligence. Annual reports, concalls, segment notes, red flags. Screener AI and Multibagg Iris live here. Job four is portfolio hygiene. What you own, concentration, and event risk on holdings. Multibagg's portfolio layer is built for that.

News is a fifth stream, not a fifth AI. Moneycontrol and broker apps win breaking headlines. Do not ask FinGenie to be a wire service. Do not ask Screener AI to classify the market regime. Mismatch the job and every product looks broken.

Screener remains the default fundamentals graph for a huge share of serious retail investors in India. Ten to fifteen years of financials, custom screens, custom ratios, peer comparison, Excel export, segment results, alerts, and watchlists. Premium at ₹4,999 per year unlocks the active investor version: more columns, more alerts, Excel automation, deeper insights limits, and ₹500 in Screener AI credits.

If your edge is quantitative filtering, stay here. High ROE, clean balance sheets, promoter behavior, and peer tables are Screener's home turf. FinGenie will not replace that. Multibagg will not erase a decade of Screener habit either. The stack starts with a place that stores clean company numbers.

Read more in Screener.in alternatives and the dedicated Screener AI alternative guide for the AI add-on specifically.

Screener AI sits on company pages. You ask in plain English. It reads annual reports and earnings calls already wired into Screener. No upload. No prompt theater. Screener's pitch against ChatGPT and Perplexity is correct for this job: web search misses filings. Direct document access is faster and more relevant for company questions.

Pricing is honest about tokens. Typical answers cost about ₹10 to ₹30. Heavy multi-document reads can approach ₹100. Premium includes ₹500 credits, not unlimited chat. General Intelligence mode exists for cheaper answers. That meter is fair. Document AI is expensive. Pretending otherwise is how products go bankrupt or quietly degrade quality.

Use Screener AI when you are already researching a ticker and need the filing to speak. Do not use it as your daily market briefing. That is the wrong meter and the wrong model context.

Multibagg AI packages Iris as an AI stock analyst with filings, concalls, financial tables, discovery, alerts, and portfolio connections. Shark Tank visibility accelerated distribution. The product is not only chat. Market Explorer, Market Pulse, Deep Dive, IPO tools, and watchlists surround Iris.

Pricing in the 2026 Shark Tank promo window: free Standard with about 20 Iris questions per month, Premium near ₹7,199 per year on discount, Professional near ₹8,999 per year on discount, Enterprise custom. List prices sit higher before the 40% save messaging. Paid tiers unlock more document history, more prompts, more portfolios, and advanced alerts. Always verify live numbers on the Multibagg pricing page before you subscribe.

Iris wins when the question is company or portfolio shaped. Summarize a concall. Flag portfolio concentration. Explore a theme. Scan an IPO document. FinGenie does not try to beat that corpus. Full comparison: Multibagg alternative guide.

FinGenie is FynSight's financial market intelligence AI. It answers regime, FII/DII, sector, breadth, and crypto cycle questions from published FynSight data. Free sign-in. Ten questions per day. That is roughly three hundred market questions a month without a ₹7,000 research subscription or a ₹20 filing meter.

The moat is not a bigger LLM. The moat is a daily validated pipeline that classifies market state and publishes it. Market GPS, sector ranks, flow streaks, similar setups, and crypto cycle pillars feed FinGenie. When you ask whether the rally is real, you are not asking a generic model to guess. You are querying classified breadth and regime context.

Start at FinGenie, read the FinGenie Hub, and browse the Finance AI guide. Indexed ask pages make the questions shareable. This layer is what Multibagg and Screener leave open even when they are excellent at companies.

Moneycontrol, Economic Times, and broker apps still win breaking news and order placement. FynSight explicitly does not try to be your broker or your wire. Multibagg and Screener are research surfaces, not replacements for execution venues like Zerodha or Groww.

A clean mental model: news tells you what happened. Screener and Iris help you study companies. FinGenie tells you what kind of market those companies are trading in. Your broker places the order. Mixing those layers in one chatbot creates confident nonsense.

See also Moneycontrol alternative for the news versus intelligence split.

Assume you are an active investor who wants all layers. Screener Premium ₹4,999 per year. Multibagg Premium about ₹7,199 per year on promo if you need Iris volume. Screener AI top-ups as you research names. FinGenie free for daily market Q&A. News free with ads. Broker costs separate.

You can also run a lean stack: free Screener limits, free Multibagg Standard for light Iris use, free FinGenie daily, and paid AI only when a filing question is worth ₹20. Many investors overbuy Premium before they have a market habit. Flip that. Build the free market check first. Pay for company depth when a shortlist exists.

Global tools still appear in “finance ai” search: Perplexity Finance, Fiscal.ai, ChatGPT, Hebbia. Useful for US research or general writing. Weak as native India regime engines. Keep them as optional satellites, not as your India market core. Details in best Finance AI tools 2026.

After 6:30 PM IST, open FynSight Market GPS or ask FinGenie the regime question. Note FII/DII streak and top sector. If breadth is weak and leadership is narrow, write that down before you fall in love with a stock story from social media.

Next, if you are hunting ideas, run a Screener screen aligned to your process. Then shortlist three names. For each name, use Screener AI or Multibagg Iris on filings and concalls. If you hold a portfolio, ask Iris about concentration only after you know the market character. Finally, place or skip orders in your broker. Do not reverse the order because a tipster thread felt urgent.

Weekly, reread sector ranks and similar setups on FynSight. Monthly, review whether your paid seats still match usage. If you burned twenty Iris prompts and zero market checks, you are researching stocks blind to regime. If you asked FinGenie daily and never opened a filing, you are commenting on markets without company work. Balance the stack to your actual behavior.

FinGenie is best when the question is market-shaped and India-native. Regime labels. Flow streaks. Sector leadership. Breadth. Crypto cycle. Free daily access. That lane is still under-served by Multibagg and Screener AI even though both are strong products.

FinGenie is not best for concall digests, custom ratio screens, Excel models, portfolio broker sync, or IPO RHP red-flag hunts. Saying otherwise would be marketing, not research. The winning move is category clarity: financial market intelligence AI, not fake all-in-one supremacy.

Comparisons that keep you honest: vs ChatGPT, vs Perplexity, vs Multibagg, vs Screener AI.

Mistake one: buying the tool with the loudest Shark Tank clip without mapping jobs. Mistake two: assuming free ChatGPT replaces a validated India market pipeline. Mistake three: paying per filing answer to ask regime questions. Mistake four: expecting FinGenie to summarize forty quarters of notes. Mistake five: ignoring news speed and then blaming research AI for missing an intraday headline.

Mistake six is subtle. Investors treat FII sold today as a complete story. Without streak and absorption context, that headline is incomplete. Multibagg may show activity. FinGenie is built to interpret the streak inside a regime. Use the right depth for the claim you are making.

Mistake seven: no written workflow. Tools do not create discipline. A stack without a sequence becomes tab chaos. Write your order of operations once. Stick to it for a month. Then adjust spend.

Individuals: start free across FinGenie, Screener hobby limits, and Multibagg Standard. Add Screener Premium when screens and alerts are daily. Add Multibagg Premium when Iris volume and portfolio features clearly pay for themselves in time saved. Keep FinGenie free unless a future paid tier adds alerts or higher quotas you actually use.

Small research groups: Multibagg Enterprise or shared Premium seats may matter for collaboration. Screener Premium per analyst is still cheap relative to time. FynSight public intelligence can remain the shared market brief without seat fees today. Institutions evaluating Hebbia-class document platforms are in a different budget universe. Do not force retail FinGenie into that RFP.

Students: free FinGenie plus free Screener habits beat a premature ₹9,000 Iris plan. Learn market vocabulary first. Pay for document AI when you have companies worth reading.

Open FinGenie and ask today's regime question. Bookmark Market GPS. Skim Multibagg and Screener AI comparison pages so pricing stays honest in your head. If you already pay Multibagg or Screener Premium, do not cancel. Add the market layer you were missing.

Share the stack idea with one investing friend who keeps asking which AI is best. The answer is plural. Best is a workflow, not a logo.

Company AI got funded and famous first because the demo is obvious. Upload or retrieve a PDF. Ask a question. Get a summary. Investors feel the time save immediately. Market AI is harder to demo in a Shark Tank clip because the value is a classified state that updates daily and only makes sense if you trust the underlying engines.

That divergence created a product vacuum. India now has excellent filing assistants and still leaves retail investors guessing whether an index green day was broad or narrow. FynSight chose the harder demo on purpose. FinGenie is the conversational face of that choice.

If you evaluate vendors, ask what is published every day without you prompting. Multibagg publishes research surfaces and Iris chats on demand. Screener publishes company pages and screens. FynSight publishes regime, flows, sectors, and briefs on a schedule. On-demand chat and scheduled intelligence are both valuable. They are not substitutes.

Tip culture pollutes Indian retail finance. Any AI that drifts into buy and sell theater becomes a liability. FynSight bans advisory language in product copy. FinGenie answers are framed as observations and historical patterns. Multibagg and Screener also warn that AI can err. Hold every vendor to that standard, including us.

When you read comparison blogs that promise guaranteed multibaggers from an AI stack, close the tab. A real stack reduces confusion. It does not abolish risk. Regime labels can be wrong. Filings can omit what matters. Screens can be optimized to the past. Your process still needs humility.

If you create content for others, teach the job split. Do not teach tool worship. The investor who can explain why they opened FinGenie before Iris is already ahead of the investor who bought the most expensive plan.

You have ₹5,000 a year total tool budget. Buy Screener Premium first if you live in screens. Use free FinGenie daily. Use Multibagg free tier sparingly. Top up Screener AI only for names on a shortlist.

You have ₹15,000 a year. Screener Premium plus Multibagg Premium is plausible if you research companies weekly. Keep FinGenie free. Do not spend the whole budget on global ChatGPT Plus alone and skip India-native layers.

You are a pure index SIP investor. You may not need Multibagg at all. You still benefit from FinGenie monthly to understand the market you are averaging into. Context improves behavior even when you do not stock pick.

You trade short-term. News speed and broker tools dominate. FinGenie still helps after the close so you do not confuse a headline with a regime. Screener AI helps less unless you hold names through events.

You run a small advisory desk. Check your regulations before any AI touches client advice. Use FynSight as market context research, Screener for fundamentals, and never present FinGenie output as a personalized recommendation.

Screener is best at fundamentals infrastructure. Screener AI is best at metered filing Q&A on company pages. Multibagg Iris is best at packaged stock and portfolio AI with a clear paid ladder. FinGenie is best at free daily India market intelligence Q&A grounded in published FynSight engines.

If someone forces you to crown a single winner for all of finance AI in India, refuse the premise. Crown a workflow instead. Market character, then screens, then filings, then portfolio checks, then news, then execution. That order is the India investor AI stack for 2026.

Begin today at FinGenie. Keep the tools you already trust. Fill the market gap you have been papering over with vibes.

When friends forward yet another “best AI for stocks” reel, send them this stack. When they ask whether to cancel Multibagg after finding FinGenie, tell them no unless they never used Iris. When they ask whether FinGenie replaces Screener, tell them no. When they ask what FinGenie replaces, tell them the evening guesswork about what kind of market they just lived through.

That is the whole thesis. Company AI got crowded. Market intelligence AI still has room for a clear, free, India-native answer. FynSight and FinGenie intend to occupy that room without pretending to own every other room in the house.

Daily: Ask FinGenie regime and FII streak. Glance at top sector. Write one sentence on breadth. Weekly: Run or refresh one Screener screen. Monthly: One Iris or Screener AI deep dive on a holding. Quarterly: Review tool spend versus hours saved. Yearly: Re-read this stack and drop any subscription you did not open in ninety days.

Pre-buy checklist for any new Finance AI: What job does it own? What is the free tier limit? What is the honest paid price? Does it conflict with a tool I already pay for? Does it invent advice language I should reject? If you cannot answer those, do not enter the UPI PIN.

Pre-ask checklist before any AI prompt: Is this a market question, a screen question, a filing question, or a portfolio question? Route accordingly. Market to FinGenie. Screen to Screener. Filing to Screener AI or Iris. Portfolio to Iris. News to a news app. Execution to a broker. That routing table is worth more than any single model upgrade.